Mapi Pharma

2 stories about Mapi Pharma
נסיעת בכורה של רכבת מהירה מ ירושלים ל תל אביב

Copaxone-Competitor Developer Mapi Pharma Gets Funding for Jerusalem Plant

19.03.19|Lilach Baumer
The clinical-stage company develops more efficient versions of existing successful drugs, including a long-acting version of Teva's multiple sclerosis cash cow
default image

Drug Developer Mapi Pharma Raises $10 Million from China's Jingxin Pharm

06.11.18|Lilach Baumer
The Xinchang, China-headquartered generic drugmaker is an existing investor, having made an initial $10 million investment in Mapi in 2016